Europace · 18 Nov 2026
Venous Vascular Closure System Versus Conventional Figure of Eight Suture Following Single Shot Device Pulmonary Vein Isolation: The VASC-AF Study
Christian-Hendrik Heegerh-index 17, Henning Rolfes, Louis Töllner, Tilman Maurer, Arian Sultan, Julia Vogler, Stephan Willems, Annalena Feibel, Fariba Rafieé, Alexander Ghanem, Martin W Bergmannh-index 4
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Aims Optimization of femoral venous access management has become increasingly important as catheter ablation of atrial fibrillation (AF) continues to evolve towards greater safety with accelerated recovery pathways. We evaluated the efficacy and safety of a bioabsorbable venous vascular closure system (VCS) compared with a conventional figure-of-eight (F8) suture and manual compression following contemporary single-shot pulmonary vein isolation (PVI). Methods and Results VASC-AF was a prospective, multicentre, randomized controlled trial performed at three German electrophysiology centres. One hundred consecutive patients undergoing single-shot PVI were randomized in a 1:1 ratio to femoral venous closure using the VASCADE MVP VCS; (n=50) or conventional F8 suture (n=50). The primary efficacy endpoint was time to ambulation. The primary safety endpoint comprised major periprocedural adverse events requiring medical intervention before hospital discharge. Baseline characteristics and procedural variables were comparable between study groups. Median time to ambulation was significantly shorter following vascular closure with VCS compared with F8 sutures (120 [120–150] vs. 180 [180–240] min; P=0.015). Likewise, time to haemostasis (0.5 [0.5–2] vs. 1 [1–2] min; P=0.021) and time to discharge eligibility (2.5 [2.1–3.0] vs. 4.0 [3.0–5.0] h; P=0.019) were significantly reduced. Major adverse events occurred infrequently and did not differ significantly between groups. In contrast, vascular closure using VCS significantly reduced minor vascular access complications (6% vs. 26%; P=0.006), groin pain, and patient discomfort while improving overall post-procedural satisfaction. Conclusion Among patients undergoing contemporary single-shot AF ablation, use of a bioabsorbable VCS significantly accelerated post-procedural recovery while maintaining a comparable major safety profile. Reduced access-site complications and improved patient-reported outcomes support VCS as an important component of enhanced recovery pathways following AF ablation especially in an ambulatory or Same-Day Discharge setting.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Christian-Hendrik Heeger has the highest h-index among the authors (17).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (0)
What it cites, from open citation data, with Crossref's record of each.